Read Financial Articles on Day Trading, Investment, Stock Market, NIFTY, BSE, NSE, Mutual Fund, Commodities and ETF
JACKPOT PACKAGE: Get 95%+ Accuracy in our premium package. Charges only Rs.5000/Month.
To Get Free Trial Just SMS JACKPOT and your Name to 9999961207 or Call Us.
Share Gyan launches new website for COMMODITY TIPS. Register for free trial @ CommodityGyan.in now!


News Tagged as ‘Sun Pharma’

Sun Pharmacy rushes high

Friday, July 3, 2009 10:25 am No Comments

Sun Pharmacy presently trades on the higher side on the Sensex after the company got a hesitant consent from the USFDA for its ANDA for the generic edition of Optivar.

By ShareGyan.com NewsDesk Tags: , , , , ,

Sun Pharmacy profits with drug sanction

Monday, March 30, 2009 10:42 am No Comments

6282 shares traded on the Sensex. The stock saw a standard everyday volume of 51,018 shares in the last quarter.

By ShareGyan.com NewsDesk Tags: , , , ,

Generic pharmacy’s cost cut

Wednesday, February 4, 2009 10:05 am No Comments

Generic pharmacy companies have done well despite the slump, but they are not totally resistant to the commotion of the international financial system.

By ShareGyan.com NewsDesk Tags: , , , ,

Tender bid’s expiration date extended by Sun Pharma

Friday, January 30, 2009 9:50 am No Comments

Sun Pharmaceutical Industries has declared that its subordinate, Alkaloida Chemical Company Exclusive Group, has moved further the expiration date of the tender bid for the acquisition of all outstanding regular shares of Taro Pharmaceutical Industries.

By ShareGyan.com NewsDesk Tags: ,

Sun Pharma refuses Taro’s demand for $15 a share

Thursday, January 8, 2009 1:50 pm No Comments

Sun Pharma has turned down the Taro’s offer cueing it was beyond its worth, which did not reveal audited results for three years and restated accounts.

By ShareGyan.com NewsDesk Tags: ,

Taro refuses Sun Pharma’s amended proposals

Tuesday, January 6, 2009 12:16 pm No Comments

Indian drug major Sun Pharma’s efforts to settle the ongoing litigation with Taro Pharma by sending two amended proposals have been discarded by the latter.

By ShareGyan.com NewsDesk Tags: ,

Copyright © 2009 ShareGyan.com. All rights reserved.

Disclaimer: Trading or investing in stocks & commodities is a high risk activity. Any action you choose to take in the markets is totally your own responsibility. ShareGyan.com will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.

Disclosure: The information on this website is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. The writers may or may not be trading in the securities mentioned.